Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Doubremelle

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
La Revue De Medecine Interne|March 27, 2003
[Antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae mannan antibodies: new biological tools for diagnosis of inflammatory bowel disease]A Bourreille, M Doubremelle, J-F Colombel
Gastroenterologie Clinique Et Biologique|December 17, 1998
[Ischemic colitis after taking flutamide]J Barouk, M Doubremelle, R Faroux, et al.
Scandinavian Journal of Gastroenterology|June 11, 2003
RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn diseaseA Bourreille, M Doubremelle, D Raingeard de la Blétière, et al.
Scandinavian Journal of Gastroenterology|April 27, 2017
RDP58, a Novel Immunomodulatory Peptide with Anti-Inflammatory Effects. A Pharmacological Study in Trinitrobenzene Sulphonic Acid Colitis and Crohn DiseaseA Bourreille, M Doubremelle, D Raingeard de la Blétière, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
La Revue De Medecine Interne|March 27, 2003
[Antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae mannan antibodies: new biological tools for diagnosis of inflammatory bowel disease]A Bourreille, M Doubremelle, J-F Colombel
Gastroenterologie Clinique Et Biologique|December 17, 1998
[Ischemic colitis after taking flutamide]J Barouk, M Doubremelle, R Faroux, et al.
Scandinavian Journal of Gastroenterology|June 11, 2003
RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn diseaseA Bourreille, M Doubremelle, D Raingeard de la Blétière, et al.
Scandinavian Journal of Gastroenterology|April 27, 2017
RDP58, a Novel Immunomodulatory Peptide with Anti-Inflammatory Effects. A Pharmacological Study in Trinitrobenzene Sulphonic Acid Colitis and Crohn DiseaseA Bourreille, M Doubremelle, D Raingeard de la Blétière, et al.
Pageof 1